The Clinical Trials Market in US is being driven by Rise in number of clinical trials of drugs
The Clinical Trials Market in US is expected to grow at a CAGR of 5.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 6.5 billion. The clinical trials market in the US has experienced substantial growth and innovation, driven by technological advancements and scientific research. One such advancement is the implementation of electronic data capture (EDC) systems. EDC platforms streamline the collection, management, and analysis of clinical trial data, enabling electronic data recording from study participants. This eliminates the need for paper-based systems and manual data entry, saving time, reducing errors, and enhancing data quality. The use of EDC systems in clinical trials contributes to increased efficiency, accuracy, and safety in the testing and approval of new medications and therapies.
Get more information on Clinical Trials Market in US by requesting a sample report
The market is segmented based on segments_for_ai.nslist
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
166 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.3% |
Market growth 2025-2029 |
USD 6.5 billion |
Market structure |
Fragmented |
YoY growth 2024-2025(%) |
5.0 |
Key countries |
US |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
In the US, biopharmaceutical and medical device companies are significantly increasing R&D investments in clinical trials to bring new drug candidates, including small-molecule drugs and biologics, to market. Contract Research Organizations (CROs), clinical research organizations, and healthcare workers collaborate in these trials. Technological advancements, such as genomics, AI, IoT, real-world data, patient-centric trials, and virtual trials, are revolutionizing the clinical trials landscape. For instance, Interferon-beta treatment for diseases like Multiple Sclerosis is a testament to the technological evolution in clinical trials. The focus is shifting towards more efficient, people-centric trials that leverage the latest technologies to improve outcomes and accelerate the development of new treatments. Traditional clinical trials continue to play a crucial role in this process.
The Clinical Trials Market in the US is a significant segment of the larger, global Life Science Tools and Services Market. Key players in this market include biopharmaceutical companies, medical device firms, Contract Research Organizations (CROs), and raw material suppliers. These entities contribute to the development of various drug candidates, including small-molecule drugs, biologics, biosimilars, and large-molecule drugs. The market's expansion is driven by factors such as increasing healthcare expenditure, the growing aging population, and the rising demand for personalized medicines. Healthcare workers and clinical research organizations are essential collaborators in this process. The market's growth is also fueled by the increasing adoption of advanced technologies and outsourcing trends.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted